These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

912 related items for PubMed ID: 30743203

  • 21. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
    Xu J, Duan X, Hu F, Poorun D, Liu X, Wang X, Zhang S, Gan L, He M, Zhu K, Ming Z, Chen H.
    J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
    [Abstract] [Full Text] [Related]

  • 22. Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8-MyD88-NF-κB-NLRP3 Inflammasome Pathway.
    Yang BY, Cheng YG, Liu Y, Liu Y, Tan JY, Guan W, Guo S, Kuang HX.
    Molecules; 2019 Jun 07; 24(11):. PubMed ID: 31181689
    [Abstract] [Full Text] [Related]

  • 23. Serine deficiency exacerbates psoriatic skin inflammation by regulating S-adenosyl methionine-dependent DNA methylation and NF-κB signalling activation in keratinocytes.
    Meng Q, Liu Y, Yao L, Ma Z, Guo L, Hu T, Luo Y, Chen J, Dang E, Li Z.
    J Eur Acad Dermatol Venereol; 2024 Jan 07; 38(1):145-156. PubMed ID: 37669859
    [Abstract] [Full Text] [Related]

  • 24. Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3/IL-23 axis.
    Chen L, Huang D, Huang Z, Liu X, He M, Luo M, Tang Z, Tan G, Guo Q, Xiong H.
    Int Immunopharmacol; 2024 May 30; 133():112033. PubMed ID: 38608446
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways.
    Kim N, Lee S, Kang J, Choi YA, Jang YH, Jeong GS, Kim SH.
    Molecules; 2021 Oct 08; 26(19):. PubMed ID: 34641629
    [Abstract] [Full Text] [Related]

  • 28. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
    Park KD, Kim N, Kang J, Dhakal H, Kim JY, Jang YH, Lee WJ, Lee SJ, Kim SH.
    Int Immunopharmacol; 2021 Sep 08; 98():107883. PubMed ID: 34153674
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways.
    Sangaraju R, Alavala S, Nalban N, Jerald MK, Sistla R.
    Int Immunopharmacol; 2021 Jul 08; 96():107754. PubMed ID: 34162135
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Sinomenine Suppressed Keratinocyte Proliferation and Imiquimod-Induced Psoriasis-Like Dermatitis by Regulating lncRNA XIST.
    Xiang S, Wu X, Xiang Y.
    Skin Pharmacol Physiol; 2022 Jul 08; 35(6):328-342. PubMed ID: 35960313
    [Abstract] [Full Text] [Related]

  • 34. BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis.
    Irrera N, Vaccaro M, Bitto A, Pallio G, Pizzino G, Lentini M, Arcoraci V, Minutoli L, Scuruchi M, Cutroneo G, Anastasi GP, Ettari R, Squadrito F, Altavilla D.
    Clin Sci (Lond); 2017 Mar 01; 131(6):487-498. PubMed ID: 28096316
    [Abstract] [Full Text] [Related]

  • 35. Ginsenoside Compound K Reduces Psoriasis-related Inflammation by Activation of the Glucocorticoid Receptor in Keratinocytes.
    Wang W, Xu X, Yang M, Jiang M, Wang D, Tang C, Wei W, Chen J.
    Curr Mol Pharmacol; 2024 Feb 21; 17():e18761429254358. PubMed ID: 38389423
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
    Gao J, Guo J, Nong Y, Mo W, Fang H, Mi J, Qi Q, Yang M.
    BMC Pharmacol Toxicol; 2020 Jun 03; 21(1):41. PubMed ID: 32493482
    [Abstract] [Full Text] [Related]

  • 38. Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin.
    Amigó M, Payá M, De Rosa S, Terencio MC.
    Br J Pharmacol; 2007 Oct 03; 152(3):353-65. PubMed ID: 17641670
    [Abstract] [Full Text] [Related]

  • 39. Tetrastigma hemsleyanum polysaccharides alleviate imiquimod-induced psoriasis-like skin lesions in mice by modulating the JAK/STAT3 signaling pathway.
    Lv Y, Yang L, Mao Z, Zhou M, Zhu B, Chen Y, Ding Z, Zhou F, Ye Y.
    Phytomedicine; 2024 Oct 03; 133():155917. PubMed ID: 39153275
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.